HORIZON-MISS-2023-CANCER-01-03
HORIZON-MISS-2023-CANCER-01-03
Programme: Horizon Europe
5 projects · €37,496,606 total EU contribution (project-level) · 88 participating organizations · 16 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€37,496,606
Countries active
Participant organizations by country (headquarters in CORDIS).
- Italy (15)
- Germany (14)
- AT (9)
- Spain (8)
- BE (6)
- Netherlands (6)
- DK (5)
- France (5)
- UK (4)
- CH (3)
- EL (3)
- IE (3)
- SE (3)
- IL (2)
- CZ (1)
- PL (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- STICHTING AMSTERDAM UMC3 projects · NL
- CHARITE - UNIVERSITAETSMEDIZIN BERLIN2 projects · DE
- REGIONH2 projects · DK
- AUH1 projects · DK
- AIT1 projects · AT
- UNIBO1 projects · IT
- AUSL ROMAGNA1 projects · IT
- CHU LILLE1 projects · FR
- CHILDREN'S HEALTH IRELAND1 projects · IE
- GERMAN CANCER RESEARCH CENTER1 projects · DE
- UT1 projects · DE
- HELLENIC SOCIETY OF HAEMATOLOGY1 projects · EL
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Personalised response monitoring in oncology: co-creating clinical trials in advanced breast cancer PREMIO COLLAB · 101136812 | HORIZON | €7,537,801 | €0 | Details |
Residual disease assessment in hematologic malignancies to improve patient-relevant outcomes across Europe (RESOLVE) RESOLVE · 101136502 | HORIZON | €8,000,000 | €456,825 | Details |
Diagnostic HER2DX-guided treatment for patients with early-stage HER2-positive breast cancer DEFINITIVE · 101136953 | HORIZON | €7,999,930 | €0 | Details |
Endoscopic brush cytology and single cell clinal dynamics of early easophageal adenocarcinoma for detecting cost effective surveillance strategies and prediction of cancer recurrence ENDEAVOR · 101136935 | HORIZON | €6,726,489 | €501,563 | Details |
A SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis MONALISA · 101137028 | HORIZON | €7,232,386 | €200,500 | Details |